Nosmen

Nosmen Dosage/Direction for Use

etoricoxib

Manufacturer:

Biolab

Distributor:

Biopharm

Marketer:

Biopharm
Full Prescribing Info
Dosage/Direction for Use
NOSMEN is administered orally. NOSMEN may be taken with or without food. NOSMEN should be administered for the shorted duration possible and the lowest effective daily dose should be used.
Osteoarthritis: The recommended dose is 60 mg once daily.
Rheumatoid Arthritis: The recommended dose is 60 mg or 90 mg once daily.
Ankylosing Spondylitis: The recommended dose is 60 mg or 90 mg once daily.
Chronic musculo-skeletal pain, including chronic low back pain: The recommended dose is 60 mg once daily.
Acute pain: For acute pain conditions, NOSMEN should be used only for the acute symptomatic period limited to a maximum of 8 days.
Acute Gouty Arthritis: The recommended dose is 120 mg once daily.
Post-operative Dental pain: The recommended dose is 90 mg once daily should be used a maximum of 3 days.
Primary Dysmenorrhea: The recommended dose is 120 mg once daily should be used a maximum of 8 days.
Post-operative abdominal gynecological pain: The recommended dose is 90 mg or 120 mg once daily.
Elderly, Gender, Race: No dosage adjustment in etoricoxib is necessary for the elderly or based on gender or race.
Hepatic Impairment: Etoricoxib should not be given to patients with severe hepatic impairment (Child-Pugh 10 or more), maximum 60 mg daily in mild hepatic impairment (Child-Pugh score 5 to 6), maximum 60 mg on alternate days or 30 mg once daily in moderate hepatic impairment (Child-Pugh score 7 to 9).
Renal Impairment: In patients with advanced renal disease (creatinine clearance < 30 mL/min), treatment with etoricoxib is not recommended. No dosage adjustment is necessary for patients with lesser degrees of renal impairment (creatinine clearance ≥ 30 mL/min).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in